From: A meta-analysis of ventriculostomy-associated cerebrospinal fluid infections
Study (Author-Date) | Representativeness | Demonstration that outcome not present at outset | Assessment of outcome (proven infection vs suspected infection based on other criteria) | Adequacy of follow-up (<5% loss) |
---|---|---|---|---|
Alleyne 2000 [31] | * | * | * | * |
Arabi 2005 [36] | * | Â | Â | * |
Bota 2005 [35] | * | * | * | * |
Camacho 2011 [8] | * | * | Â | * |
Chi 2009 [24] | * | * | * | * |
Dasic 2006 [10] | * | Â | * | * |
Fichtner 2010 [28] | * | * | Â | |
Hader 2000 [17] | * | * | * | * |
Hoefnagel 2008 [2] | * | * | * | Â |
Holloway 1996 [25] | Â | Â | * | |
Khalil 2005 [9] | * | * | * | * |
Kim 2012 [34] | * | * | * | * |
Kitchen 2011 [6] | Â | Â | * | * |
Lemcke 2012 [20] | * | * | * | * |
Leverstein Van-Dall 2010 [21] | * | Â | Â | * |
Lo 2007 [18] | * | * | Â | * |
Lundberg 2000 [16] | * | * | Â | |
Lwin 2012 [27] | * | Â | * | * |
Lyke 2001 [13] | * | * | * | * |
Mahe 1995 [7] | * | Â | Â | * |
McLaughlin 2012 [19] | Â | Â | Â | * |
Moon 2007 [12] | * | Â | * | * |
Park 2004 [29] | * | * | * | * |
Rafiq 2011 [15] | * | * | * | * |
Rivero-Garvia 2011 [26] | * | Â | Â | * |
Roitberg 2001 [30] | Â | Â | * | |
Scheithauer 2009 [23] | * | * | Â | * |
Scheithauer 2010 [22] | * | * | Â | * |
Schodel 2012 [32] | * | Â | * | * |
Schultz 1993 [11] | * | * | * | |
Sloffer 2005 [33] | Â | * | * | * |
Smigoc 2012 [5] | * | * | * | |
Smith 1976 [4] | * | Â | * | Â |
Williams 2011 [14] | * | * | * | * |
Wyler 1972 [3] | * | Â | * | * |